Correlation between the Severity of Metabolic Dysfunction-Associated Fatty Liver Disease and Serum Uric Acid to Serum Creatinine Ratio

Table 3

Univariate and multivariate linear regression analyses of liver/spleen computed tomography ratio.

Analysis method	Indicators	Unstandardized coefficients		Standardized coefficients	t
		B	Std. error	β
Univariate analysis
sUA/Cr		−0.033	0.011	−0.204	−3.126	0.002
Sex		−0.112	0.031	−0.230	−3.555	<0.001
Age		0.002	0.001	0.099	1.502	0.135
BMI		−0.020	0.004	−0.308	−4.863	<0.001
Dyslipidemia		−0.114	0.035	−0.214	−3.292	0.001
Abnormal liver function		−0.147	0.027	−0.342	−5.472	<0.001
Abdominal obesity		−0.064	0.041	−0.104	−1.576	0.116
Hypertension		−0.028	0.031	−0.059	−0.881	0.379
Diabetes		−0.049	0.057	−0.057	−0.853	0.395
Smoking history		−0.050	0.030	−0.112	−1.693	0.092
Drinking history		−0.067	0.029	−0.151	−2.289	0.023
Multivariate analysis
sUA/Cr		−0.025	0.010	−0.154	−2.439	0.016
Sex		−0.064	0.033	−0.131	−1.914	0.057
BMI		−0.012	0.004	−0.184	−2.892	0.004
Dyslipidemia		−0.075	0.032	−0.141	−2.319	0.021
Abnormal liver function		−0.101	0.027	−0.236	−3.753	<0.001
Drinking history		−0.003	0.029	−0.008	−0.117	0.907

sUA/Cr, serum uric acid to serum creatinine ratio; BMI, body mass index.